Posts

Showing posts with the label Pharma Report

Cervical Cancer Market is Expected to Increase With a CAGR of 16.9% for the Study Period of 2017-2030 in 7MM: DelveInsight

  Cervical Cancer Market is Expected to Increase With a CAGR of 16.9% for the Study Period of 2017-2030 in 7MM: DelveInsight LAS VEGAS, US (DelveInsight)--   The coming decade is expected to witness a rise in targeted therapies in the pipeline and a better drug delivery approach that shall give the  cervical cancer market  a boost. An increase in cervical cancer incidence is also a major reason behind the accelerated momentum of the cervical cancer market size growth. Further, increased healthcare spending, better diagnosis, and heightened R&D to facilitate a better understanding and increased awareness of the disease are some other driving factors.  View report: https://www.delveinsight.com/report-store/cervical-cancer-market Some of the key insights from  cervical cancer market  report:  The incidence of cervical cancer in 7MM (US, UK, Germany, Italy, Spain, France & Japan) ...

Carcinoid Tumor Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

 (Albany, NY) Delveinsight has launched a new report on " Carcinoid Tumor Market Insights, Epidemiology, and Market Forecast-2030 ”.   DelveInsight's " Carcinoid Tumor Market Insights, Epidemiology, and Market Forecast-2030 "   report delivers an in-depth understanding of the Carcinoid Tumor , historical and forecasted epidemiology as well as the Carcinoid Tumor market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.   Some of the facts: ·          Literature studies suggest that women are more likely to develop carcinoid tumors than men. ·          The incidence of Neuroendocrine tumors was approximately 2/100,000 with a female preponderance under the age of 50 years due to appendiceal location. The main primary sites were the gastrointestinal tract (62–67%) and the lung (22–27%). Presentation with metastatic disease accounts for ...

Bipolar Depression Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

(Albany, NY) DelveInsight has launched a new report on “ Bipolar Depression Market Insight, Epidemiology and Market Forecast -2030 .”   DelveInsight's " Bipolar Depression Market Insights and Forecast Report " delivers an in-depth understanding of the Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression market trends, pipeline scenario, Bipolar Depression market drivers, barriers, and forecasted analysis in the 7MM for the study period 2017-30.   Some of the Facts: ·          As per DelveInsight analysts, the total diagnosed prevalent population of Bipolar Depression in the 7MM was 1,857,545 in 2017. ·          The estimates show the highest diagnosed prevalence of Bipolar Depression in the United States with 740,715 cases in 2017. ·          Bipolar I and Bipolar II are the major subtypes of BD. ·   ...

Progressive Multifocal Leukoencephalopathy Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

DelveInsight has launched a new report on " Progressive Multifocal Leukoencephalopathy Market Insights, Epidemiology, and Market Forecast-2030 ."     DelveInsight's " Progressive Multifocal Leukoencephalopathy Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Progressive Multifocal Leukoencephalopathy , historical and forecasted epidemiology as well as the Progressive Multifocal Leukoencephalopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.   Some of the Facts: ·          Each year, it is estimated that 4000 people develop PML in the United States and Europe combined. ·          PML occurs in approximately one in 200,000 people. ·          PML is associated with both HIV-1 and HIV-2. ·      ...